Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 3 |
NetGPI | no | yes: 0, no: 3 |
Related structures:
AlphaFold database: E9ANQ0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.560 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.554 |
CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.748 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.477 |
DEG_APCC_DBOX_1 | 32 | 40 | PF00400 | 0.508 |
DEG_SCF_FBW7_2 | 162 | 169 | PF00400 | 0.515 |
DOC_MAPK_gen_1 | 21 | 29 | PF00069 | 0.569 |
DOC_MAPK_MEF2A_6 | 152 | 160 | PF00069 | 0.537 |
DOC_PP2B_LxvP_1 | 41 | 44 | PF13499 | 0.467 |
DOC_USP7_MATH_1 | 111 | 115 | PF00917 | 0.623 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.580 |
DOC_USP7_UBL2_3 | 87 | 91 | PF12436 | 0.586 |
DOC_WW_Pin1_4 | 146 | 151 | PF00397 | 0.599 |
DOC_WW_Pin1_4 | 162 | 167 | PF00397 | 0.542 |
DOC_WW_Pin1_4 | 98 | 103 | PF00397 | 0.586 |
LIG_14-3-3_CanoR_1 | 104 | 108 | PF00244 | 0.582 |
LIG_14-3-3_CanoR_1 | 42 | 48 | PF00244 | 0.572 |
LIG_14-3-3_CanoR_1 | 66 | 75 | PF00244 | 0.482 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.647 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.657 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.579 |
LIG_FHA_1 | 36 | 42 | PF00498 | 0.470 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.576 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.484 |
LIG_FHA_2 | 163 | 169 | PF00498 | 0.516 |
LIG_Integrin_RGD_1 | 33 | 35 | PF01839 | 0.485 |
LIG_Integrin_RGD_TGFB_3 | 33 | 39 | PF01839 | 0.465 |
LIG_SH2_CRK | 100 | 104 | PF00017 | 0.588 |
LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.704 |
LIG_SH3_3 | 144 | 150 | PF00018 | 0.628 |
LIG_TRAF2_1 | 114 | 117 | PF00917 | 0.614 |
LIG_TRAF2_1 | 118 | 121 | PF00917 | 0.596 |
LIG_TRAF2_1 | 128 | 131 | PF00917 | 0.519 |
LIG_TRAF2_1 | 166 | 169 | PF00917 | 0.620 |
LIG_TYR_ITIM | 98 | 103 | PF00017 | 0.586 |
MOD_CDC14_SPxK_1 | 149 | 152 | PF00782 | 0.518 |
MOD_CDK_SPxK_1 | 146 | 152 | PF00069 | 0.525 |
MOD_CDK_SPxK_1 | 98 | 104 | PF00069 | 0.587 |
MOD_CK1_1 | 142 | 148 | PF00069 | 0.631 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.495 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.582 |
MOD_CK2_1 | 111 | 117 | PF00069 | 0.621 |
MOD_CK2_1 | 142 | 148 | PF00069 | 0.631 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.484 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.522 |
MOD_GlcNHglycan | 141 | 144 | PF01048 | 0.788 |
MOD_GlcNHglycan | 70 | 73 | PF01048 | 0.598 |
MOD_GlcNHglycan | 90 | 94 | PF01048 | 0.626 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.583 |
MOD_N-GLC_1 | 67 | 72 | PF02516 | 0.538 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.615 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.649 |
MOD_PIKK_1 | 16 | 22 | PF00454 | 0.472 |
MOD_PKA_2 | 103 | 109 | PF00069 | 0.614 |
MOD_PKA_2 | 139 | 145 | PF00069 | 0.527 |
MOD_Plk_4 | 35 | 41 | PF00069 | 0.638 |
MOD_Plk_4 | 92 | 98 | PF00069 | 0.553 |
MOD_ProDKin_1 | 146 | 152 | PF00069 | 0.596 |
MOD_ProDKin_1 | 162 | 168 | PF00069 | 0.541 |
MOD_ProDKin_1 | 98 | 104 | PF00069 | 0.587 |
MOD_SUMO_rev_2 | 125 | 134 | PF00179 | 0.621 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.777 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IHI7 | Leishmania donovani | 76% | 71% |
Q4QGX3 | Leishmania major | 74% | 100% |